LeadIQ logo
Learn more at LeadIQ.com

Insights

Immunotherapy Leader Dendreon is a pioneer in immunotherapy, with their flagship product, PROVENGE, being the first FDA-approved immunotherapy for advanced prostate cancer. This innovative edge positions them as a leader in the field and opens doors for collaborations and partnerships.

Expansion Opportunities Dendreon's recent launch of Provenge for prostate cancer treatment indicates their focus on expanding their product portfolio. This presents potential sales opportunities for offering comprehensive solutions to healthcare providers and reaching a broader patient base.

Key Executive Appointments With recent key appointments like a new CEO and VP of sales and market access, Dendreon is strategically reinforcing its leadership team. Leveraging the expertise of these professionals can lead to enhanced sales strategies and market penetration.

Financial Resilience Having revenues in the range of $100M - 1B signifies Dendreon's financial stability and market presence. This financial resilience can instill confidence in potential clients and investors, paving the way for successful sales engagements and partnerships.

Competitive Positioning Given the landscape of similar companies working in biotechnology research, such as Cytovia Therapeutics, Bavarian Nordic, and NantKwest, Dendreon's unique offerings and historical success with PROVENGE differentiate them in the market. Understanding and leveraging this competitive advantage can drive sales growth.

Similar companies to Dendreon

Dendreon Tech Stack

Dendreon uses 8 technology products and services including Hyperion, Google Font API, RMS, and more. Explore Dendreon's tech stack below.

  • Hyperion
    Corporate Performance Management
  • Google Font API
    Font Scripts
  • RMS
    Hotel Management
  • Google Maps
    Maps
  • Priority Hints
    Performance
  • Amazon Web Services
    Platform As A Service
  • Microsoft ASP.NET
    Web Frameworks
  • Nginx
    Web Servers

Media & News

Dendreon's Email Address Formats

Dendreon uses at least 1 format(s):
Dendreon Email FormatsExamplePercentage
FLast@dendreon.comJDoe@dendreon.com
74%
First.Last@dendreon.comJohn.Doe@dendreon.com
25%
FirstLast@dendreon.comJohnDoe@dendreon.com
1%

Frequently Asked Questions

Where is Dendreon's headquarters located?

Minus sign iconPlus sign icon
Dendreon's main headquarters is located at 1700 Saturn Way Seal Beach , CA 90740 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Dendreon's phone number?

Minus sign iconPlus sign icon
You can contact Dendreon's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dendreon's stock symbol?

Minus sign iconPlus sign icon
Dendreon is a publicly traded company; the company's stock symbol is DNDNQ.

What is Dendreon's official website and social media links?

Minus sign iconPlus sign icon
Dendreon's official website is dendreon.com and has social profiles on LinkedIn.

How much revenue does Dendreon generate?

Minus sign iconPlus sign icon
As of August 2024, Dendreon's annual revenue reached $750M.

What is Dendreon's SIC code NAICS code?

Minus sign iconPlus sign icon
Dendreon's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dendreon have currently?

Minus sign iconPlus sign icon
As of August 2024, Dendreon has approximately 610 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: B. B.Chief Sales Officer: J. R.Vice President Of Medical Affairs: S. F.. Explore Dendreon's employee directory with LeadIQ.

What industry does Dendreon belong to?

Minus sign iconPlus sign icon
Dendreon operates in the Biotechnology Research industry.

What technology does Dendreon use?

Minus sign iconPlus sign icon
Dendreon's tech stack includes HyperionGoogle Font APIRMSGoogle MapsPriority HintsAmazon Web ServicesMicrosoft ASP.NETNginx.

What is Dendreon's email format?

Minus sign iconPlus sign icon
Dendreon's email format typically follows the pattern of . Find more Dendreon email formats with LeadIQ.

When was Dendreon founded?

Minus sign iconPlus sign icon
Dendreon was founded in 1992.
Dendreon

Dendreon

Biotechnology ResearchCalifornia, United States501-1000 Employees

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif. 

Section iconCompany Overview

Headquarters
1700 Saturn Way Seal Beach , CA 90740 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
DNDNQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1992
Employees
501-1000

Section iconFunding & Financials

  • $100M$1B

    Dendreon's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Dendreon's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.